Ken Fisher
RCUS icon

Ken Fisher’s Arcus Biosciences RCUS Stock Holding History

Ken Fisher’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$66M Sell
2,139,396
-51,008
-2% -$1.26M 0.02% 213
2026
Q1 		$47.3M Buy
2,190,404
+240,616
+12% +$5.2M 0.02% 244
2025
Q4 		$46.5M Buy
1,949,788
+1,220,635
+167% +$24.9M 0.02% 244
2025
Q3 		$9.92M Buy
729,153
+640,990
+727% +$6.66M ﹤0.01% 410
2025
Q2 		$718K Sell
88,163
-49,475
-36% -$423K ﹤0.01% 738
2025
Q1 		$1.08M Buy
+137,638
New +$1.6M ﹤0.01% 668

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

Ken Fisher's RCUS Position: Q2 2026 in Review

Ken Fisher reduced its Arcus Biosciences (RCUS) stake by 2.3% in Q2 2026, selling an estimated $1.26M and leaving 2,139,396 shares worth $66M. The position accounts for 0.02% of the portfolio, ranked #213.

Ken Fisher first reported a position in RCUS in Q1 2025 and has held it in 6 quarters since. 51 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • Ken Fisher held 2,139,396 shares of Arcus Biosciences worth $66M as of Q2 2026.
  • Ken Fisher sold 51,008 Arcus Biosciences shares in Q2 2026, an estimated $1.26M.
  • Arcus Biosciences made up 0.02% of Ken Fisher's portfolio in Q2 2026, its #213 holding.
  • Ken Fisher first reported a position in Arcus Biosciences in Q1 2025 and has held it in 6 quarters since.
  • 51 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on Fisher Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.